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Item S1: Definitions of atherosclerotic and non-atherosclerotic vascular events 
 
Atherosclerotic vascular event 
Major atherosclerotic event (MAE): 
 Major coronary events: non-fatal myocardial infarction or coronary death 
 Ischaemic stroke 
 Arterial revascularization: coronary or non-coronary (excluding interventions on haemodialysis 
access) 
Plus: 
 Other atherosclerotic coronary events: unstable angina, heart failure related to ischaemic heart 
disease 
 Other atherosclerotic cerebrovascular events: transient ischaemic attack, amaurosis fugax, 
retinal artery occlusion 
 Other atherosclerotic peripheral arterial disease:  
o aortic aneurysm (including rupture and dissection) 
o limb ischaemia, limb artery embolism or thrombosis 
 
Non-atherosclerotic vascular event 
Non-atherosclerotic cardiac events: 
 Non-coronary cardiac death 
 Heart failure not related to ischaemic heart disease (hypertrophic cardiomyopathy, cor 
pulmonale) 
 Arrhythmias: atrial fibrillation, ventricular tachycardia, other tachycardia, bradycardia/heart 
block, other arrhythmia, cardiac arrest 
 Valvular heart disease (including valve repair or replacement) 
 Pericardial disease: pericarditis, effusion 
Other non-atherosclerotic events: 
 Haemorrhagic stroke 
 Subarachnoid haemorrhage 
 
